Lexeo Therapeutics (LXEO) Enterprise Value (2022 - 2023)
Historic Enterprise Value for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to -$35.4 million.
- Lexeo Therapeutics' Enterprise Value rose 6234.96% to -$35.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$35.4 million, marking a year-over-year increase of 6234.96%. This contributed to the annual value of -$77.3 million for FY2022, which is N/A changed from last year.
- Latest data reveals that Lexeo Therapeutics reported Enterprise Value of -$35.4 million as of Q3 2023, which was up 6234.96% from -$77.3 million recorded in Q4 2022.
- In the past 5 years, Lexeo Therapeutics' Enterprise Value registered a high of -$35.4 million during Q3 2023, and its lowest value of -$94.2 million during Q3 2022.